Calibr at Scripps Research
D. Elshan Nakath G. Ralalage has a diverse work experience in the field of medicinal chemistry. D. Elshan started their career as a Researcher at the University of Colombo, where they conducted research on the design, synthesis, and biological evaluation of a vesicular monoamine transporter inhibitor. D. Elshan then worked as an Assistant Manager at Pharm House Pharmacy, where they managed various aspects of the business and served as an assistant pharmacist.
Afterwards, they joined Sanofi as an Intern in Medicinal Chemistry, gaining experience in the pharmaceutical industry and participating in a drug discovery project. D. Elshan then worked at the University of Arizona as a Researcher in Medicinal Chemistry, targeting specific cell surface receptors and mentoring undergraduate students.
D. Elshan furthered their career at UCLA as a Scientist in Medicinal Chemistry, focusing on the development of novel drugs for metastatic castration-resistant prostate cancer under the guidance of renowned professors. D. Elshan continued their research work at Calibr at Scripps Research, first as an Investigator and then as a Principal Investigator and later as Associate Director - Medicinal Chemistry. In these roles, they led multiple research areas, managed internal teams and collaborations, contributed to synthesis efforts and project milestone decisions, and progressed a major discovery project.
Throughout their career, D. Elshan Nakath G. Ralalage has demonstrated expertise in medicinal chemistry, project management, and team leadership, and has made significant contributions to various research projects in the field.
D. Elshan Nakath G. Ralalage began their education journey in 2004 at the University of Colombo, where they pursued a Bachelor of Science degree in Chemistry, which they completed in 2008. Following their undergraduate studies, they joined the University of Arizona in 2009 for their doctoral research. They successfully obtained a Doctor of Philosophy (Ph.D.) degree in Chemistry in 2014. Subsequently, in 2015, they continued their academic pursuit as a Postdoctoral Scholar at UCLA, specializing in Medicinal and Pharmaceutical Chemistry.
Calibr at Scripps Research
1 followers
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.